M&A Transactions in Regulated Sector

Strategic legal guidance on M&A in highly regulated sectors. Anthony, Linder & Cacomanolis provides expert analysis on Fintech licensing, Healthcare CHOW, Cannabis compliance, and Crypto/Securities law integration.

M&A in Regulated Sectors: Navigating Complex Gatekeepers in Fintech, Healthcare, Cannabis, and Crypto

In highly regulated industries, the execution of an M&A transaction—whether a de-SPAC, reverse merger, or traditional asset purchase—requires more than contractual precision; it requires a deep understanding of the regulatory gatekeepers that control the right to operate. In these sectors, “closing” is often contingent on the approval of multiple state and federal agencies whose timelines and requirements can fundamentally alter deal economics. Anthony, Linder & Cacomanolis provides sophisticated counsel to issuers and investors, facilitating the navigation of licensing transfers, Change of Ownership (CHOW) mandates, and specialized securities law disclosures.

1. Fintech and Financial Services: The Licensing Mosaic

Fintech M&A involves the intersection of traditional banking regulations and modern digital delivery systems. Acquirers must account for both federal oversight and the complex web of state-level money transmitter laws.

Money Transmitter Licensing (MTL) and Change of Control

Most Fintech entities (payments, remittances, wallets) operate under state MTLs.

• Prior Approval Requirements: Many states require prior approval for a “change of control” (typically defined as the acquisition of 10% to 25% of the voting stock). Failure to obtain pre-approval can result in the immediate suspension of the license, effectively paralyzing the target’s operations post-closing.
• FinCEN and AML/KYC Compliance: Under the Bank Secrecy Act (BSA), the acquirer must perform rigorous due diligence on the target’s Anti-Money Laundering (AML) and Know Your Customer (KYC) frameworks. Successor liability for historical AML failures is a primary risk factor in Fintech deal-making.

Consumer Protection and the CFPB

Transactions involving consumer-facing financial products must satisfy the standards of the Consumer Financial Protection Bureau (CFPB) regarding Unfair, Deceptive, or Abusive Acts or Practices (UDAAP).

2. Healthcare: Licensure, AKS, and Stark Law Compliance

Healthcare M&A is defined by the rigid structures of federal reimbursement programs and state professional licensure rules.

Change of Ownership (CHOW) and Provider Enrollment

• Medicare/Medicaid Impact: The transfer of healthcare assets often triggers a “Change of Ownership” process. Acquirers must navigate the 855A enrollment process and account for potential “successor liability” for historical overpayments or audits by the Centers for Medicare & Medicaid Services (CMS).
• State Licensure: Many states require a new license application rather than a simple transfer, which can lead to operational “blackouts” if not synchronized with the closing.

The Anti-Kickback Statute (AKS) and Stark Law

Transactions involving physician-owned targets or referral-based businesses must be analyzed for compliance with the AKS and the Stark Law.

• Fair Market Value (FMV): The purchase price must be supportable as fair market value and cannot take into account the volume or value of future referrals.
• Corporate Practice of Medicine (CPOM): In states with strict CPOM doctrines, we structure transactions using “Management Services Organization” (MSO) models to ensure that non-physician acquirers do not inadvertently violate state laws prohibiting the practice of medicine by business corporations.

3. Cannabis: Navigating the Federal-State Conflict

The cannabis industry remains uniquely challenged by the conflict between state-level legalization and federal illegality under the Controlled Substances Act.

State Licensure and Residency Requirements

• Transfer Restrictions: Most state cannabis regulators impose strict “suitability” checks on new owners. Some jurisdictions still maintain “residency requirements” for owners, though these are increasingly subject to constitutional challenges under the Dormant Commerce Clause.
• Vertical Integration Limits: Many states limit the number of licenses a single entity can hold, necessitating strategic “divestiture” planning in larger acquisitions.

Section 280E and Financial Due Diligence

Because of the federal prohibition, cannabis businesses cannot deduct ordinary business expenses under Internal Revenue Code Section 280E. We assist acquirers in evaluating the target’s historical tax compliance, as 280E liabilities are a common source of post-closing valuation disputes.

4. Crypto and Digital Assets: The Howey Test and Beyond

M&A in the crypto sector is currently defined by the SEC’s “regulation by enforcement” approach and the evolving definition of what constitutes a security.

Securities Act Integration and the Howey Test

Acquirers must determine if the target’s tokens or digital assets are classified as “investment contracts” under the Howey test.

• Secondary Market Liability: If the target has sold unregistered securities, the acquirer may inherit significant rescission liabilities and SEC enforcement risk.
• de-SPAC Disclosures: In a de-SPAC involving a crypto target, the SEC requires exhaustive disclosure regarding the technical architecture of the blockchain, the decentralization of the network, and the custodial risks associated with digital asset storage.

AML/KYC and “Travel Rule” Compliance

Crypto targets must demonstrate compliance with the FinCEN “Travel Rule,” which requires the transmission of specific originator and beneficiary information for certain digital asset transfers.

Strategic Provisions for Regulated M&A

We ensure that the definitive agreement accounts for these industry-specific risks through:

• Regulatory “Hell-or-High-Water” Clauses: Defining the level of effort required to obtain necessary licensing approvals.
• Specific Indemnities: Ring-fencing known regulatory risks, such as pending CMS audits or state cannabis compliance investigations.
• Deferred Closings and “Carve-Out” Structures: Allowing for the closing of non-regulated assets while waiting for licensing approvals on regulated business units.

Authority Through Professional Experience

Our firm’s expertise in regulated sector M&A is grounded in a deep history of professional analysis and advocacy. We invite executive leadership to explore our extensive library of insights at our corporate website and our specialized blog site, www.securitieslawblog.com, for detailed discussions on Fintech MTL requirements and the impact of the 2024 SEC rules on crypto-asset disclosures.

Schedule an Executive Strategy Consultation

Executing a transaction in a tightly regulated field requires an authoritative partner who understands the intersection of industry-specific licensing and federal securities law. Anthony, Linder & Cacomanolis invites you to engage in a high-level strategy consultation to evaluate your transaction’s regulatory roadmap.

Schedule an executive strategy consultation with our senior partners to discuss your regulated sector M&A needs by calling 877-541-3263 or visiting our contact page.